We curate a digest of the latest news in our field for advocates, policymakers, community coalitions and all who work toward shaping policies and practices to effectively prevent substance use and treat addiction.
View our curated digest of the latest research news, including the association between the concurrent use of e-cigarettes and cannabis with COVID-19 symptoms, testing and diagnosis among college student e-cigarette users.
New York City health officials are planning to install 10 “public health vending machines” around the city that will dispense the opioid overdose antidote naloxone, as well as sterile syringes.
A new study finds significant increases in the frequency and severity of emergency department visits due to marijuana exposures in children in Ontario, Canada, after the legalization of recreational marijuana.
Overdose deaths reached almost one million in the United States from 1999 through 2020, according to a new study by the Centers for Disease Control and Prevention.
Doctors using a program to increase buprenorphine treatment for opioid use disorder were able to boost use of the medication sixfold, HealthDay reports.
Many flavored vaping products continue to be sold despite a federal judge’s ruling that should have led to them being pulled from the market, according to a report by the Campaign for Tobacco-Free Kids.
Harm reduction groups are calling on the Biden administration to make the opioid overdose reversal medication naloxone available to them over-the-counter, NPR reports. Currently, naloxone is a prescription drug. These groups must meet a series of requirements to purchase naloxone from drug companies.
View our curated digest of the latest research news, including the relationship between tobacco product use and medical opioid use in rural areas of the U.S.
The Substance Abuse and Mental Health Services Administration on Wednesday announced a $30 million harm reduction program to help address the nation’s substance use and overdose epidemic, Newsweek reports.
More than 10% of patients who receive a pacemaker or other implantable cardiac device and fill an opioid prescription after surgery consistently take the medication for months afterwards, a new study finds. This raises the potential for addiction, researchers report in the journal Circulation.
This website uses cookies. We use cookies and similar technologies to give you the best experience. By using this website, you accept our Privacy Policy and Terms of Use.
Get Support
